Receptor tyrosine-protein kinase erbB-2 (689-697)

Receptor tyrosine-protein kinase erbB-2 (689-697) is a synthetic peptide fragment corresponding to amino acids 689 through 697 of the erbB-2 protein, also known as HER2/neu. This peptide segment is derived from a region of the erbB-2 receptor, a member of the epidermal growth factor receptor (EGFR) family that plays a pivotal role in cellular signaling pathways related to growth, differentiation, and survival. The erbB-2 protein is of significant interest in molecular biology and cancer research due to its involvement in oncogenic processes and its utility as a model system for understanding receptor tyrosine kinase function. As a defined peptide sequence, erbB-2 (689-697) serves as a valuable tool for probing the structural and functional dynamics of protein-protein interactions, post-translational modifications, and immune recognition associated with the HER2/neu axis.

Epitope mapping: The peptide sequence representing erbB-2 (689-697) is frequently employed in epitope mapping studies to identify antibody binding sites and to characterize immunodominant regions within the HER2/neu receptor. By providing a defined and reproducible antigenic determinant, this peptide enables researchers to dissect the specificity of monoclonal and polyclonal antibodies, facilitating the development of immunoassays and the refinement of antibody-based detection strategies in basic and translational research.

Signal transduction research: As a segment of the intracellular domain of HER2/neu, the 689-697 peptide is instrumental in investigating the molecular mechanisms governing receptor-mediated signaling. Researchers utilize this peptide to examine phosphorylation events, kinase-substrate interactions, and downstream effector recruitment, thereby elucidating the regulatory pathways that control cell proliferation and differentiation. Such studies are critical for advancing the understanding of tyrosine kinase activity and its impact on cellular homeostasis.

Peptide-based assay development: The defined nature of the erbB-2 (689-697) peptide makes it an ideal substrate or standard in the development of peptide-based biochemical assays. It is commonly incorporated into ELISA, immunoblotting, and mass spectrometry workflows to quantify antibody responses, validate assay specificity, or calibrate detection systems. The use of this peptide enhances assay reproducibility and enables precise measurement of immunological or enzymatic activity related to HER2/neu.

Protein-protein interaction studies: Investigators use the erbB-2 (689-697) sequence to probe interactions between HER2/neu and intracellular signaling partners or regulatory proteins. By incorporating this peptide into binding assays or pull-down experiments, it becomes possible to define the molecular determinants of interaction specificity, affinity, and competition within complex signaling networks. These insights are valuable for mapping interaction interfaces and for guiding the rational design of modulators targeting the HER2/neu pathway.

Immunogenicity assessment: The peptide is also leveraged in immunological studies to assess T-cell or B-cell recognition of the HER2/neu receptor. By presenting this defined epitope to immune cells in vitro, researchers can evaluate antigen processing, presentation, and recognition mechanisms, providing crucial data for vaccine design, immune monitoring, and the study of anti-tumor immunity in preclinical research settings.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line